| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |